September 9, 2025
Five in A Row! Alnylam Named a 2025 Best Workplace for Innovators by Fast Company
We're proud to be named a Best Workplace for Innovators by Fast Company for the 5th year in a row.
Read More ›
August 26, 2025
RNAi Therapeutics: 5 Things You Should Know about this Innovative Class of Medicines
What is RNAi and what do RNAi therapeutics do? Here are 5 things you should know!
Read More ›
August 11, 2025
Everest and Everything In Between: A Journey Back to Nepal
One Alnylam employee's personal and spiritual journey home to Nepal and Everest to raise money for cancer research.
Read More ›
July 13, 2025
Supporting Newcomer Entrepreneurs - Forward·Inc’s Challengers Pitch Competition
Alnylam recently sponsored Forward·Inc’s Challengers Pitch Competition, as part of our ongoing Alnylam Challengers social impact initiative.
Read More ›
May 20, 2025
Alnylam Publishes 2024 Corporate Responsibility Report
We've published our 2024 Corporate Responsibility Report detailing our efforts in our pillars: Patients, Science, Employees, Communities, Planet, and Governance
Read More ›
May 1, 2025
Challenge Accepted: How Culture Powers Innovation at Alnylam
Alnylam's Chief Human Resources Officer discusses how the company's culture powers innovation and our mission to transform lives through RNAi therapeutics.
Read More ›
March 25, 2025
2024 Year in Review & Look Ahead: CEO Yvonne Greenstreet Highlights a Pivotal Year for Aln ...
Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2024 and highlights of the 2024 annual report.
Read More ›
February 21, 2025
A New Therapeutic Approach Seeks to Silence Devastating Neurological Diseases
Exploring the potential of RNAi therapeutics to tackle brain diseases with few or no treatments
Read More ›
February 3, 2025
Alnylam Named a Newsweek Most Responsible Company for 2025
Alnylam has been named one of Newsweek's America's Most Responsible Companies for 2025, our third year in a row.
Read More ›
January 9, 2025
Supporting Refugees in Europe: Alnylam Challengers and the Path to Empowerment
Arun Skaria, Alnylam's Head of DEI and Corporate Responsibility provides an update on Alnylam's efforts to support refugees in Europe
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site